Consistent with our findings, in an asthma model treated with serine protease inhibitors, Lin et al. [24] showed that reduced airway hyperresponsiveness was associated with reduced IL-5, IL-6, and IL-13 in BALF fluid, and IL-4 in the serum. This evidence concerns the gene IL5 and airway hyperresponsiveness.